Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Chris Hyungseop Han picked up the Award of Excellence at the 74th Annual International Magnesium Association (IMA) World Magnesium Conference held in Singapore last month.

Dr. Jan Guy (Immediate Past President, Executive Committee Member, Board of Directors of IMA) (left) Chris Hyungseop Han (right)

The IMA Awards of Excellence program, established in 1962, is an annual program open to all researchers and companies demonstrating outstanding examples of magnesium's use. Nominations are judged by a peer review panel of international experts and winners are recognised worldwide. 

Chris won the award of excellence for his research in the development of Biodegradable Magnesium Alloy for Orthopaedic Applications. 

Often a patient will need two parts of their bones screwed together, which then results in a second operation to have the screws removed. For the past 8 years, Chris has been a part of a research team that overcame these limitations and created a roadmap to the next generation of metallic biodegradable implant materials with completely biocompatible elements. A state of the art method to synchronise the corrosion potential was developed to control the corrosion rate. 

Working closely with major hospitals in Korea, the research team have performed several hundred cases of small bone fixation screws and the results have been promising. The BBC World News ‘Horizons’ programme recently featured the team’s research as a medical breakthrough.

Chris commented:

"I am deeply honoured to have received the award of excellence from IMA. I would like to thank my family, my supervisors (Dr James Edwards and Professor Sion Glyn-Jones), my mentors at Korea Institute of Science and Technology (Dr. Hyun-Kwang Seok and Dr. Yu-Chan Kim) and the U&I Corporation for their support over the years. I am hoping to collaborate with more professionals at Oxford to explore the new possibilities of these biodegradable metallic materials." 

 

clinical Trial Published Clinical Trial Published on PNAS

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.